Evidence mapPaperPMID 33446272Full record

ArticleSystematic reviews2021

Effectiveness of interventions to increase uptake and completion of treatment for diabetic retinopathy in low- and middle-income countries: a rapid review protocol.

Covadonga Bascaran, Nyawira Mwangi, Fabrizio D'Esposito, Charles Cleland, Iris Gordon, Juan Alberto Lopez Ulloa, Ranad Maswadi, Shaffi Mdala, Jacqueline Ramke, Jennifer R Evans and 1 more

Open access · goldAbstract read
In one paragraph

Article in Systematic reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease.The Journal of pharmacology and experimental therapeutics · 2023
    Review
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Covadonga BascaranLondon School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. Covadonga.bascaran@lshtm.ac.uk.ORCID 0000-0002-5662-3325
Nyawira MwangiLondon School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Fabrizio D'EspositoThe Fred Hollows Foundation, Melbourne, Australia.
Charles ClelandLondon School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Iris GordonLondon School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Juan Alberto Lopez UlloaCentro Mexicano de Salud Visual Preventiva, Mexico DF, Mexico.
Ranad MaswadiSt Thomas's Hospital, Westminster Bridge Road, London, SE1 7EH, UK.
Shaffi MdalaQueen Elizabeth Central Hospital, P.O.Box 95, Blantyre, Malawi.
Jacqueline RamkeLondon School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Jennifer R EvansLondon School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Matthew BurtonLondon School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
University of London · GBKenya Medical Training College · KEQueen Elizabeth Central Hospital · MWSt Thomas' Hospital · GB

Funding

Wellcome TrustWellcome Trust 207472/Z/17/Z
6 · The paper itself

Abstract

backgroundVision loss due to diabetic retinopathy can largely be prevented or delayed through treatment. Patients with vision-threatening diabetic retinopathy are typically offered laser or intravitreal injections which often require more than one treatment cycle. However, treatment is not always initiated, or it is not completed, resulting in poor visual outcomes. Interventions aimed at improving the uptake or completion of treatment for diabetic retinopathy can potentially help prevent or delay visual loss in people with diabetes.

methodsWe will search MEDLINE, Embase, Global Health and Cochrane Register of Studies for studies reporting interventions to improve the uptake of treatment for diabetic retinopathy (DR) and/or diabetic macular oedema (DMO), compared with usual care, in adults with diabetes. The review will include studies published in the last 20 years in the English language. We will include any study design that measured any of the following outcomes in relation to treatment uptake and completion for DR and/or DMO: (1) proportion of patients initiating treatment for DR and/or DMO among those to whom it is recommended, (2) proportion of patients completing treatment for DR and/or DMO among those to whom it is recommended, (3) proportion of patients completing treatment for DR and/or DMO among those initiating treatment and (4) number and proportion of DR and/or DMO rounds of treatment completed per patient, as dictated by the treatment protocol. For included studies, we will also report any measures of cost-effectiveness when available. Two reviewers will screen search results independently. Risk of bias assessment will be done by two reviewers, and data extraction will be done by one reviewer with verification of 10% of the papers by a second reviewer. The results will be synthesised narratively. DISCUSSION: This rapid review aims to identify and synthesise the peer-reviewed literature on the effectiveness of interventions to increase uptake and completion of treatment for DR and/or DMO in LMICs. The rapid review methodology was chosen in order to rapidly synthesise the available evidence to support programme implementers and policy-makers in designing evidence-based health programmes and public health policy and inform the allocation of resources. SYSTEMATIC REVIEW REGISTRATION: OSF osf.io/h5wgr.

Indexed as

Diabetes MellitusDiabetic RetinopathyMacular EdemaDeveloping CountriesHumansIncomeSystematic Reviews as TopicDiabetic retinopathyLow- and middle-income countriesPatient acceptance of health careTreatment outcome

Identifiers

PMID33446272
PMCPMC7809874
OpenAlexW3107001192

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.